Riskpilot← Back to searchSign inGet full accessJBA MEDICAL AB
ABActiveOrg 5592020118Fjelie Prästgårdsväg 1All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20190 employees
Revenue 2024
SEK 1M
+5% vs 2023
EBITDA margin
85.7%
+4% vs 2023
Equity ratio
96.2%
Financial strength
Net profit 2024
SEK 699K
+4% vs 2023
| Revenue | SEK 1M | +5% |
| EBITDA | SEK 881K | +4% |
| Net profit | SEK 699K | +4% |
| Total assets | SEK 2,2M | +30% |
| Equity | SEK 2,1M | +30% |
| Employees | 0 | — |
Legal name
JBA MEDICAL AB
Org number
5592020118
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
9 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom medicinsk och klinisk kvalitetssäkring, patientsäkerhet, riskhantering, medicinsk forskning och utveckling, medicinsk utbildning och träning, läkarvård inom öppen och sluten vård, och därmed förenlig verksamhet. Därutöver skall bolaget bedriva ledarutveckling och utveckling av managementfunktioner.
Address
Fjelie Prästgårdsväg 1
Email
jbahegbrant@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 235 | 952 | 975 | 1 028 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | 1 211 | 875 | 850 | 881 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 1 211 | 875 | 850 | 881 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 1 210 | 874 | 850 | 880 |
| Tax | −0 | −249 | −180 | −175 | −181 |
| Net profit | 0 | 961 | 694 | 675 | 699 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 50 | 1 146 | 1 425 | 1 688 | 2 188 |
| Equity | 50 | 1 011 | 1 340 | 1 620 | 2 104 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 135 | 85 | 68 | 83 |
| Total debt | — | 135 | 85 | 68 | 83 |
EBITDA margin
85.7%
This company
15.8%
Market median
+442% vs market
20202024
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
33.2%
This company
18.4%
Market median
+80% vs market
20202024
Net profit margin
68.0%
This company
8.1%
Market median
+740% vs market
20202024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JBA MEDICAL AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| K W Jonathan Erdling Hegbrant | Deputy Board Member | 0 companies |
| Jörgen Börje Albin Hegbrant | Board of Directors | 0 companies |